Acrobiosystems for English
icon_bulk_orderBulk inquiry/Quick order
There is no goods in the shopping cart !
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0-9
Your Position: Home > CD138


Brief Information

Target Synonym:Syndecan Proteoglycan 1,CD138 Antigen,SYND1,SDC,Heparan Sulfate Proteoglycan Fibroblast Growth Factor Receptor,Syndecan,CD138,Syndecan-1,SDC1,Syndecan 1
Number of Launched Drugs:0
Number of Drugs in Clinical Trials:2
Lastest Research Phase:Phase 2 Clinical

Product ListCompare or Buy

By Product Status:
By Product Category:
By Species:
By Conjugate:
Cat. No. Species Product Description Structure Purity Feature
HGS-S253 Mouse Recombinant Monoclonal Anti-CD138 Antibody, Mouse (5G4)
ACRO Quality

Clinical Drug Information

Name Research Code Research Phase Company Indications Clinical Trials
CART-138 (Chinese PLA General Hospital) Phase 2 Clinical Pla General Hospital Liver Neoplasms; Ovarian Neoplasms; Pancreatic Neoplasms; Multiple Myeloma; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Breast Neoplasms; Brain Neoplasms; Colorectal Neoplasms Details
ATLCAR.CD138 (UNC Lineberger Comprehensive Cancer Center) Phase 1 Clinical Unc Lineberger Comprehensive Cancer Center Multiple Myeloma; Immune System Diseases Details

This web search service is supported by Google Inc.

Call us
Call us
North America:
+1 800-810-0816 (Toll Free)
Asia & Pacific:
+86 400-682-2521
+1 888-377-6111
1 Innovation Way, Newark, DE 19711, USA

Leave a message